ZYNE - Zynerba Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5143.21M
Enterprise Value 373.37M
Trailing P/E N/A
Forward P/E 1-4.02
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.35
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.24

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-38.85%
Return on Equity (ttm)-70.72%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -32.73M
Net Income Avi to Common (ttm)-32.01M
Diluted EPS (ttm)-2.48
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)62.51M
Total Cash Per Share (mrq)4.61
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)9.17
Book Value Per Share (mrq)4.50

Cash Flow Statement

Operating Cash Flow (ttm)-25.84M
Levered Free Cash Flow (ttm)-14.69M

Trading Information

Stock Price History

Beta 4.94
52-Week Change 3-54.62%
S&P500 52-Week Change 313.44%
52 Week High 323.84
52 Week Low 35.42
50-Day Moving Average 39.42
200-Day Moving Average 310.98

Share Statistics

Avg Vol (3 month) 3317.83k
Avg Vol (10 day) 3301.61k
Shares Outstanding 513.56M
Float 11.46M
% Held by Insiders 120.65%
% Held by Institutions 132.92%
Shares Short 32.72M
Short Ratio 35.61
Short % of Float 324.12%
Shares Short (prior month) 32.79M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A